Lombard Endovastec

Lombard Endovastec, also known as Lombard Medical Limited, is a UK-based medical device company that specializes in the minimally invasive treatment of aortic disease. Founded in 1994 and headquartered in Didcot, UK, the company focuses on the research, development, manufacturing, and sales of advanced stent graft systems for aortic endovascular repair. Following its acquisition by Shanghai MicroPort Endovascular MedTech in 2024, Lombard Medical has strengthened its presence in Europe and is expanding into the US and Japan. The company offers a diverse range of stent graft systems, including the Aorfix™, Altura™, Minos™, Meridian™, Hercules™, and Castor™ devices. These products are designed to provide customized and precise treatment solutions for complex abdominal and thoracic aortic conditions. Lombard Medical is committed to maintaining high-quality standards, with its products compliant with major regulatory approvals such as CE, FDA, and PMDA. The company serves a global customer base, including hospitals and vascular specialists, and supports clinicians through its Clinical Specialist Sales Team.

• Employees120
• Founded1994
• Annual Revenue$12169000
• Total Funding$96000000